Observational study / 2013
Higher peridiagnostic fasting blood glucose and BMI ≥ 25 kg/m² were associated with increased risks of recurrence and metastasis in breast cancer patients.
In a retrospective study of 1,261 women treated for stage I-III breast cancer followed for a median of 9.5 years, risks of distant metastasis were significantly higher across all higher glucose quintiles versus the lowest (<87 mg/dL) (HRs: 1.99, 1.85, 1.73, and 1.91). Recurrence risk was also significantly higher in all upper glucose quintiles, and all-cause death risk was higher in quintiles 2, 4, and 5. Women with BMI ≥ 25 kg/m² had significantly greater risks of recurrence and distant metastasis than those with BMI < 25 kg/m², with mediation analysis showing glucose and BMI had independent effects.
Shows an association, not proof of cause and effect.
- Study type
- Retrospective cohort study
- Who was studied
- 1,261 women diagnosed and treated for stage I-III breast cancer
- What was measured
- Distant metastasis, recurrence, and all-cause death
THE PAPER
Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study.
Contiero P, Berrino F, Tagliabue G, Mastroianni A, Di Mauro MG, Fabiano S, Annulli M, Muti P. Breast Cancer Res Treat, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.